Freda C Lewis-Hall Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Freda C Lewis-Hall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Freda C Lewis-Hall. Freda C Lewis-Hall is Executive Vice President in PFIZER INC ($PFE) and Director in TENET HEALTHCARE CORP ($THC) and EVP, Medicines Development in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in EXACT SCIENCES CORP ($EXAS) and Director in 1Life Healthcare Inc ($ONEM) and Director in SpringWorks Therapeutics, Inc. ($SWTX).
Freda C Lewis-Hall in VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Freda C Lewis-Hall: EVP, Medicines Development
Holdings: 53,334 shares
Current Value: $4,631,525
Latest Transaction: Mar 20 2009
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Freda C Lewis-Hall in VERTEX PHARMACEUTICALS INC / MA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ONEM, EXAS, PFE, SWTX, THC, VRTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2009 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Sell | S | 29.11 | 1,250 | 36,388 | 53,334 | 54.6 K to 53.3 K (-2.29 %) |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Option Exercise | A | 33.55 | 90,625 | 3,040,469 | 90,625 | |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Grant | A | 0.01 | 12,084 | 121 | 54,584 | 42.5 K to 54.6 K (+28.43 %) |
| Dec 22 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Sell | S | 29.90 | 1,250 | 37,375 | 42,500 | 43.8 K to 42.5 K (-2.86 %) |
| Dec 12 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Sell | S | 26.00 | 1,098 | 28,548 | 43,750 | 44.8 K to 43.8 K (-2.45 %) |
| Dec 12 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Sell | S | 26.00 | 152 | 3,952 | 44,848 | 45 K to 44.8 K (-0.34 %) |
| Jun 19 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Option Exercise | A | 33.47 | 100,000 | 3,347,000 | 100,000 | |
| Jun 19 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Grant | A | 0.01 | 10,000 | 100 | 45,000 | 35 K to 45 K (+28.57 %) |
| Jun 19 2008 | VRTX | VERTEX PHARMACEUTI ... | Lewis-Hall Freda C | EVP, Medicines Deve ... | Grant | A | 0.01 | 35,000 | 350 | 35,000 | 0 to 35 K |
Page: 1